You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 19, 2024

LINCOMYCIN HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Lincomycin Hydrochloride, and what generic alternatives are available?

Lincomycin Hydrochloride is a drug marketed by Arthur Grp, Gland Pharma Ltd, Micro Labs, Slate Run Pharma, Slayback, and Xgen Pharms. and is included in six NDAs.

The generic ingredient in LINCOMYCIN HYDROCHLORIDE is lincomycin hydrochloride. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the lincomycin hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Lincomycin Hydrochloride

A generic version of LINCOMYCIN HYDROCHLORIDE was approved as lincomycin hydrochloride by XGEN PHARMS on June 4th, 2015.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LINCOMYCIN HYDROCHLORIDE?
  • What are the global sales for LINCOMYCIN HYDROCHLORIDE?
  • What is Average Wholesale Price for LINCOMYCIN HYDROCHLORIDE?
Drug patent expirations by year for LINCOMYCIN HYDROCHLORIDE
Recent Clinical Trials for LINCOMYCIN HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tan Tock Seng HospitalPhase 4
Menzies School of Health ResearchPhase 4
The Peter Doherty Institute for Infection and ImmunityPhase 4

See all LINCOMYCIN HYDROCHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for LINCOMYCIN HYDROCHLORIDE

US Patents and Regulatory Information for LINCOMYCIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arthur Grp LINCOMYCIN HYDROCHLORIDE lincomycin hydrochloride INJECTABLE;INJECTION 212770-001 Mar 12, 2021 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Slate Run Pharma LINCOMYCIN HYDROCHLORIDE lincomycin hydrochloride INJECTABLE;INJECTION 216662-001 Dec 21, 2022 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gland Pharma Ltd LINCOMYCIN HYDROCHLORIDE lincomycin hydrochloride INJECTABLE;INJECTION 215657-001 Sep 26, 2022 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Micro Labs LINCOMYCIN HYDROCHLORIDE lincomycin hydrochloride INJECTABLE;INJECTION 215082-001 Nov 8, 2021 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xgen Pharms LINCOMYCIN HYDROCHLORIDE lincomycin hydrochloride INJECTABLE;INJECTION 201746-001 Jun 4, 2015 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Slayback LINCOMYCIN HYDROCHLORIDE lincomycin hydrochloride INJECTABLE;INJECTION 063180-001 Apr 16, 1991 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.